Otros idiomas Biohaven Ltd.

Acciones

BHVN

VGG1110E1079

Precio de cierre Nyse Otros sitios de cotización 00:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
34,71 ^USD	-1,08 %		+3,43 %	-18,90 %

29/05	Biohaven Ltd. Presenta una amplia cartera innovadora y actualizaciones de su cartera de productos en múltiples áreas terapéuticas, como la inmunología, la neurociencia, los trastornos metabólicos y la oncología, en el Día Anual de I+D para Inversores	CI
29/05	Biohaven dosifica a la primera paciente su novedoso conjugado de anticuerpo y fármaco (ADC) dirigido a Trop-2 BHV-1510 en tumores epiteliales avanzados o metastásicos	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Biohaven Ltd. Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas Including Immunology, Neuroscience, Metabolic Disorders and Oncology At Annual Investor R&D Day	29/05
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors	29/05
Certain Stock Options of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2024.	18/05
Certain Common Shares of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2024.	18/05
Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing	15/05
Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing	14/05
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates	10/05
Biohaven Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	25/04
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	23/04
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	23/04
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	23/04
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	18/04
Biohaven Prices $230 Million Public Share Offering	18/04
Biohaven Launches $200 Million Common Stock Offering	17/04
North American Morning Briefing : Stocks Struggle After New Records	22/03
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	29/02
Biohaven Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Biohaven Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02
Biohaven Ltd. acquired Pyramid Biosciences, Inc. for $50 million.	29/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Biohaven Ltd.

Acciones

BHVN

VGG1110E1079

Otros idiomas

Filtros